Published in Ann Surg on December 01, 2003
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg (2004) 1.59
Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care (2011) 1.52
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg (2007) 1.38
Biliary complications in liver transplantation. Hepatol Int (2008) 0.87
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts. World J Gastroenterol (2014) 0.84
Hepatic hemodynamic changes during liver transplantation: a review. World J Gastroenterol (2014) 0.81
Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79
Validation of graft and standard liver size predictions in right liver living donor liver transplantation. Hepatol Int (2011) 0.79
The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute. Pediatr Surg Int (2016) 0.77
Hypothermia predicts hepatic failure after extensive hepatectomy in mice. World J Hepatol (2013) 0.75
Liver graft hyperperfusion in the early postoperative period promotes hepatic regeneration 2 weeks after living donor liver transplantation: A prospective observational cohort study. Medicine (Baltimore) (2016) 0.75
Hepatic hemodynamics and portal flow modulation: The A2ALL experience. Transplantation (2017) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft. Ann Surg (2000) 1.86
Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg (2000) 1.82
Right lobe graft in living donor liver transplantation. Transplantation (2000) 1.82
Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg (2003) 1.63
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Surgical management of anatomical variations of the right lobe in living donor liver transplantation. Ann Surg (2000) 1.38
Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl (2001) 1.38
Preoperative measurement of segmental liver volume of donors for living related liver transplantation. Hepatology (1993) 1.36
Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg (2003) 1.32
Biliary reconstruction and complications of right lobe live donor liver transplantation. Ann Surg (2002) 1.31
Modified right liver graft from a living donor to prevent congestion. Transplantation (2002) 1.16
The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08
Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl (2001) 1.05
Graft size assessment by preoperative computed tomography in living related partial liver transplantation. Br J Surg (1993) 0.98
Donor hepatectomy for living related partial liver transplantation. Surgery (1993) 0.97
Hepatic venoplasty in living-donor liver transplantation using right lobe graft with middle hepatic vein. Transplantation (2003) 0.91
Adult-to-adult living liver transplantation. Adv Surg (2001) 0.84
[Living donor liver transplantation of the right liver lobe between adults]. Dtsch Med Wochenschr (2002) 0.83
Liver transplantation using a right liver lobe from a living donor. Transplant Proc (2002) 0.81
Successful hepatic vein reconstruction in 42 consecutive living related liver transplantations. Surgery (2000) 0.80
Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuit. J Cardiovasc Surg (Torino) (1989) 0.79
Living orthotopic liver transplant using right lobe: our experience in the first 19 donors. Transplant Proc (2001) 0.78
Efficacy and safety of heat exchanger added to venovenous bypass circuit during orthotopic liver transplantation. Liver Transpl Surg (1998) 0.77
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology (2002) 9.76
MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2002) 3.93
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med (2002) 3.84
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem (2012) 3.35
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology (2002) 2.90
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res (2006) 2.78
Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology (2003) 2.73
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg (2002) 2.42
Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39
Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg (2011) 2.38
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol (2011) 2.17
High frequency of chimerism in transplanted livers. Hepatology (2003) 2.15
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg (2004) 2.06
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci U S A (2013) 2.05
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg (2004) 1.99
Liver resection using a saline-linked radiofrequency dissecting sealer for transection of the liver. J Am Coll Surg (2005) 1.98
Optical-CT gel-dosimetry I: basic investigations. Med Phys (2003) 1.95
Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.91
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 1.89
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology (2011) 1.89
Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery (2004) 1.86
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg (2004) 1.79
Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg (2002) 1.77
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys (2005) 1.76
Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol (2002) 1.75
Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J (2009) 1.73
Polypoid lesions of the gallbladder. Am J Surg (2004) 1.73
Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B. Am J Gastroenterol (2013) 1.73
Image-guided small animal radiation research platform: calibration of treatment beam alignment. Phys Med Biol (2009) 1.72
Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys (2009) 1.70
Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol (2005) 1.66
Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem (2011) 1.63
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63
Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation (2003) 1.61
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol (2003) 1.59
Choledochal cysts in adults. Arch Surg (2002) 1.59
Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors. Liver Transpl (2007) 1.58
Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis (2004) 1.56
Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.54
External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg (2007) 1.54
Therapeutic options for esophageal cancer. J Gastroenterol Hepatol (2004) 1.52
Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther (2007) 1.49
The small-animal radiation research platform (SARRP): dosimetry of a focused lens system. Phys Med Biol (2007) 1.49
CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology (2012) 1.48
Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci U S A (2011) 1.48
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg (2008) 1.46
Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies. J Clin Oncol (2009) 1.46
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation. Liver Transpl (2003) 1.44
Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol (2005) 1.41
Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys (2004) 1.41
Hepatitis B virus-specific CD4 T cell immunity after liver transplantation for chronic hepatitis B. Liver Transpl (2009) 1.41
Small animal radiation research platform: imaging, mechanics, control and calibration. Med Image Comput Comput Assist Interv (2007) 1.40
The potential clinical utility of serial plasma albumin mRNA monitoring for the post-liver transplantation management. Clin Biochem (2013) 1.39
Colonic interposition after esophagectomy for cancer. Arch Surg (2003) 1.38
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg (2007) 1.38
Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys (2005) 1.37
Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg (2003) 1.32
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome. Cancer Biol Ther (2011) 1.32
Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys (2003) 1.31
Biliary reconstruction and complications of right lobe live donor liver transplantation. Ann Surg (2002) 1.31
The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat (2006) 1.30
Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Int J Radiat Oncol Biol Phys (2009) 1.30
Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg (2007) 1.30
SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys (2010) 1.29
Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res (2005) 1.29
Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2008) 1.29
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis (2008) 1.28
Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res (2003) 1.28
Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg (2003) 1.27
Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24
Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology (2004) 1.23
Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg (2002) 1.23